A New Dawn: First CAR T Cell Recommended for FDA Approval – Medscape
Medscape |
A New Dawn: First CAR T Cell Recommended for FDA Approval
Medscape A new dawn is breaking in the field of hematologic malignancies, as the first product based on chimeric antigen receptor (CAR) T cells was scrutinized today by a panel of experts and unanimously recommended for approval. All 10 panel members at today's … Novel cancer treatment wins endorsement of FDA advisers CAR–T gene therapy for leukemia clears FDA hurdle FDA Panel Backs Groundbreaking Novartis Treatment That Turns Your Cells Into Cancer Killers |
